$599

Merck/Pfizer Filed Ertugliflozin and FDCs in December 2016

Merck/Pfizer quietly filed their SGLT2i, ertugliflozin, FDC with metformin, and FDC with Januvia (sitagliptin) in December 2016.

This content is for Read Less members only.
Register
Already a member? Log in here